Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluzone Quadrivalent vs Trivalent in COPD
NCT02563184Phase 4Unknown
- Sponsor
- Banner Health
- Start
- Sep 2015
- Primary completion
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated) in influenza (2 cohorts), sponsored by Banner Health. Primary endpoints: Hemagglutination inhibiting antibodies at 3 months, Seroconversion at 3 months and 1 more. Status: unknown.
02
Drugs
Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02563184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02563184.